These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 2890261)

  • 21. On the characterization of dopamine-induced contractile response of rat anococcygeus muscle preparation.
    Sharma A; Kulkarni SK
    Indian J Exp Biol; 1994 Mar; 32(3):176-9. PubMed ID: 8070837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Functional interaction of dopamine receptors and chronic treatment with dopamine-antagonists].
    Barone P; Tucci I; Parashos SA
    Ann Ist Super Sanita; 1988; 24(4):547-50. PubMed ID: 3265291
    [No Abstract]   [Full Text] [Related]  

  • 23. B-HT 958 stimulates dopamine autoreceptors but blocks noradrenaline autoreceptors in the brain.
    Grabowska-Andén M; Andén NE
    J Pharm Pharmacol; 1984 Nov; 36(11):748-52. PubMed ID: 6150978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopamine-mediated behaviour following chronic treatment with B-HT 920.
    Darmani NA; Sewell RD; Nicholls PJ
    J Pharm Pharmacol; 1988 Jul; 40(7):523-4. PubMed ID: 2905000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal vascular activity of SK&F 38393 and dopamine in anesthetized dogs.
    Hahn RA; Wardell JR
    J Cardiovasc Pharmacol; 1980; 2(5):583-93. PubMed ID: 6157951
    [No Abstract]   [Full Text] [Related]  

  • 26. Selective stimulation of dopamine and noradrenaline autoreceptors by B-HT 920 and B-HT 933, respectively.
    Andén NE; Gołembiowska-Nikitin K; Thornström U
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Nov; 321(2):100-4. PubMed ID: 6296699
    [No Abstract]   [Full Text] [Related]  

  • 27. The dopamine autoreceptor agonist B-HT 920 inhibits in vivo dopamine release into the cerebroventricular system of cats.
    Pichler L; Pifl C; Hornykiewicz O; Kobinger W
    Eur J Pharmacol; 1987 Mar; 135(2):239-42. PubMed ID: 2884121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of motor activity by alpha 1- and alpha 2-adrenoceptor stimulation in mice.
    Pichler L; Kobinger W
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Sep; 317(2):180-2. PubMed ID: 6117802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of B-HT 920 and B-HT 933 on dopamine and noradrenaline autoreceptors in the rat brain.
    Andén NE; Nilsson H; Ros E; Thornström U
    Acta Pharmacol Toxicol (Copenh); 1983 Jan; 52(1):51-6. PubMed ID: 6301216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A photoaffinity label for the D-1 dopamine receptor, (RS)-7-[125I]Iodo-8-hydroxy-3-methyl-1-(4'-azidophenyl)-2,3,4,5- tetrahydro-1H-3-benzazepine, selectively identifies the ligand binding subunits of the receptor.
    Baindur N; Neumeyer JL; Niznik HB; Bzowej NH; Jarvie KR; Seeman P; Garlick RK; Miller JJ
    J Med Chem; 1988 Nov; 31(11):2069-71. PubMed ID: 3263503
    [No Abstract]   [Full Text] [Related]  

  • 31. Separation of potent central and renal dopamine agonist activity in substituted 6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepines.
    Weinstock J; Wilson JW; Ladd DL; Brush CK; Pfeiffer FR; Kuo GY; Holden KG; Yim NC; Hahn RA; Wardell JR; Tobia AJ; Setler PE; Sarau HM; Ridley PT
    J Med Chem; 1980 Sep; 23(9):973-5. PubMed ID: 7411552
    [No Abstract]   [Full Text] [Related]  

  • 32. Renal dopamine-1 defect in spontaneous hypertension.
    Felder RA; Seikaly MG; Eisner GM; Jose PA
    Contrib Nephrol; 1988; 67():71-4. PubMed ID: 3264779
    [No Abstract]   [Full Text] [Related]  

  • 33. Chronic imipramine "reverses" B-HT 920-induced hypomotility in rats.
    Serra G; Collu M; D'Aquila PS; De Montis GM; Gessa GL
    J Neural Transm Gen Sect; 1991; 84(3):237-40. PubMed ID: 1652984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Racemic and optically active 2-chloroethylcarbamoyl derivatives of 7,8-dimethoxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine: a new structural type of DA, NE and 5-T uptake inhibitors].
    Mondeshka D; Angelova I; Ivanov CB; Ivanova NS
    Arch Pharm (Weinheim); 1990 Oct; 323(10):829-32. PubMed ID: 2150477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does chronic imipramine facilitate neurotransmission at dopamine-D1 receptor level?
    Serra G; Collu M; D'Aquila PS; De Montis GM; Gessa GL
    Pharmacol Res; 1989; 21 Suppl 1():55-6. PubMed ID: 2576687
    [No Abstract]   [Full Text] [Related]  

  • 36. (3,4-Dihydroxyphenylimino)-2-imidazoline (DPI): a stimulant of alpha-adrenoceptors and dopamine receptors.
    Struyker-Boudier HA; Cools AR
    J Pharm Pharmacol; 1984 Dec; 36(12):859-60. PubMed ID: 6151987
    [No Abstract]   [Full Text] [Related]  

  • 37. [3-[2-(Dipropylamino)ethyl]phenol: a new and selective dopaminergic agent (author's transl)].
    Geissler HE
    Arch Pharm (Weinheim); 1977 Sep; 310(9):749-56. PubMed ID: 921514
    [No Abstract]   [Full Text] [Related]  

  • 38. Evidence for postsynaptic dopamine agonist effects of B-HT 920 in the presence of the dopamine D-1 agonist SKF 38393.
    Meltzer LT; Wiley JN; Williams AE; Heffner TG
    Psychopharmacology (Berl); 1988; 95(3):329-32. PubMed ID: 2901126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine D-2 receptor agonist-induced behavioural depression: critical dependence upon postsynaptic dopamine D-1 function. A behavioural and biochemical study.
    Jackson DM; Ross SB; Larsson LG
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Oct; 340(4):355-65. PubMed ID: 2573842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Occurrence of yawning and decrease of prolactin levels via stimulation of dopamine D2-receptors after administration of SND 919 in rats.
    Matsumoto S; Yamada K; Nagashima M; Domae M; Shirakawa K; Furukawa T
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Jul; 340(1):21-5. PubMed ID: 2571944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.